Pharco Pharmaceuticals is the founder of the corporation and is the second private Egyptian shareholding pharmaceutical company established in 1984. It started production in 1987 formulating, producing and marketing about 450 brands, generics, branded generics and licensed products to date.
Pharco Pharmaceuticals started with the manufacturing of antibiotics under license from Mead Johnson (now known as Bristol-Myers Squibb) and soft gelatin capsules (using RP Scherer technology), in addition to other traditional pharmaceutical forms. These products cover most of the pharmacological groups and all the conventional pharmaceutical dosage forms.
Pharco Pharmaceuticals has a separate dedicated facility for manufacturing of sterile and non-sterile Penicillin.
Pharco Pharmaceuticals has scientific offices; KSA, Yemen, UAE, Bahrain, Lebanon, Libya and Romania and exports to 53 countries. Throughout the years Pharco Pharmaceuticals has created several brands which have become market leaders in both local and international markets; Gratisovir 400mg, Rani effervescent, Fawar Fruit, Ciprofar 500 MG tablets, Spasmo Digestin, Delcophen amp, Royal jelly, Uricol effervescent, Urinex caps, Bilichol caps, Mirazid and BabyDrink. Currently a major cardiovascular line is up to date.
Pharco Pharmaceuticals is located and head quartered in Amriya, Alexandria, Egypt.